PEGASYS

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug PEGASYS contains one active pharmaceutical ingredient (API):

1 Peginterferon alpha-2a UNII Q46947FE7K - PEGINTERFERON ALFA-2A

Peginterferon alpha-2a is a pegylated interferon alfa-2a that possesses the in vitro antiviral and antiproliferative activities that are characteristic of interferon alfa-2a. Peginterferon alpha-2a is indicated for the treatment of hepatitis B and C. Read about Peginterferon alpha-2a

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PEGASYS Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AB11	Peginterferon alfa-2a	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11037X, 11416W, 6439X, 6449K, 9515T, 9516W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529204002151210
Country: CA	Health Products and Food Branch	Identifier(s): 02248077
Country: EE	Ravimiamet	Identifier(s): 1110340, 1110351, 1110362, 1110373, 1110384, 1110395, 1110407, 1110418, 1214828, 1214839, 1609523, 1609534, 1609545, 1609556, 1609567, 1609578, 1646197, 1820281, 1843905, 1847853, 1888274
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 02221006, 02221008, 102221017
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 008767, 008782
Country: FR	Base de données publique des médicaments	Identifier(s): 64347476, 67042907, 67134227
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 226859, 43381, 43384
Country: HK	Department of Health Drug Office	Identifier(s): 51529, 51530
Country: IE	Health Products Regulatory Authority	Identifier(s): 88365, 88402
Country: IT	Agenzia del Farmaco	Identifier(s): 035683034, 035683046, 035683059, 035683061, 035683073, 035683085, 035683150
Country: JP	医薬品医療機器総合機構	Identifier(s): 6399419A1022, 6399419A2029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004853, 1011191, 1011192, 1011193, 1011194, 1011195, 1030176, 1030177, 1030178, 1030179, 1064244, 1064245, 1064246, 1064247, 1064248, 1064249, 1071714
Country: NL	Z-Index G-Standaard	Identifier(s): 14753588, 14753596
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105740, 106364, 106372, 63533, 63541
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10133
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100112598, 100112606, 100112612, 100112629, 100295825
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68070001, W68070002, W68070003
Country: SG	Health Sciences Authority	Identifier(s): 12313P, 12314P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 4773014H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514950004, 8699514950257, 8699514950264, 8699514950271
Country: US	FDA, National Drug Code	Identifier(s): 0004-0350, 0004-0357
Country: ZA	Health Products Regulatory Authority	Identifier(s): 38/26/0180